熱門詞： 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
熱門詞： 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
Cell Therapeutics 美國Cell Therapeutics
Cell Therapeutic公司的arsenic trioxide(三氧化二砷)
美國FDA已批準(zhǔn)Cell Therapeutic公司的癌癥治療劑三氧化二砷用于治療脊髓發(fā)育不良癥狀(MDS)的罕見藥品的指定。MDS也稱為前期的白血病或“不完全燃燒”的白血病，MDS是骨髓不能正常起作用以及產(chǎn)生的血細(xì)胞不足。該公司最近為三氧化二砷治療另一種罕見病復(fù)發(fā)的或難治的急性早幼粒細(xì)胞白血病申報(bào)了美國的新藥申請(qǐng)書，它對(duì)這種適應(yīng)癥具有最快的跟蹤狀態(tài)，這種產(chǎn)品對(duì)治療多發(fā)性骨髓瘤具有罕見的藥品狀態(tài)
Cell Therapeutics, Inc., is a biopharmaceutical company focused on developing and commercializing novel agents that improve the safety and efficacy of existing standard-of-care chemotherapies, and those with unique,new mechanisms to kill cancer cells. We use genomic
information to determine which tumors have the greatest chance of responding favorably to a specific drug candidate.
This has the potential to change the way anticancer drugs are developed, by allowing investigators to pick the right drug for the right patient.
知識(shí)產(chǎn)權(quán)侵權(quán)投訴：不生產(chǎn)任何產(chǎn)品所有產(chǎn)品均來自產(chǎn)品的生產(chǎn)廠商、代理商、經(jīng)銷商，如有侵權(quán)請(qǐng)聯(lián)系：400-006-7520 ，我們會(huì)在第一時(shí)間處理
本網(wǎng)站所有產(chǎn)品與藥品無關(guān)
滬公網(wǎng)安備31011502016460號(hào)
